Not applicableStudy completedNCT06090305What this trial is testingEffectiveness of a Digital Health Application for Multiple Sclerosis (Levidex)Who this might be right forMultiple Sclerosis Gaia AG 470
Large-scale testing (Phase 3)Study completedNCT01201356What this trial is testingLong-term Safety and Tolerability of 0.5 mg Fingolimod in Patients With Relapsing Forms of Multiple SclerosisWho this might be right forRelapsing Forms of Multiple Sclerosis Novartis Pharmaceuticals 4,125
Not applicableStudy completedNCT02099370What this trial is testingAdherence to Treatment With Tecfidera™ in Multiple Sclerosis PatientsWho this might be right forMultiple Sclerosis University of South Florida 34
Large-scale testing (Phase 3)Study completedNCT00835770What this trial is testingBG00012 Monotherapy Safety and Efficacy Extension Study in Multiple Sclerosis (MS)Who this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 1,736
Not applicableUnknownNCT04918251What this trial is testingEEG and TMS-based Biomarkers of ALS, MS and FTDWho this might be right forAmyotrophic Lateral SclerosisFrontotemporal DementiaMultiple Sclerosis University of Dublin, Trinity College 400
Not applicableStudy completedNCT02301572What this trial is testingAggressive Onset Multiple Sclerosis: A Practical Definition and Study of Its Clinical CourseWho this might be right forMultiple Sclerosis Weill Medical College of Cornell University 750
Testing effectiveness (Phase 2)Active Not RecruitingNCT04075266What this trial is testingOcrelizumab in Children and Adolescents With Relapsing-Remitting Multiple SclerosisWho this might be right forMultiple Sclerosis Hoffmann-La Roche 23
Not applicableStudy completedNCT04655222What this trial is testingStudy to Investigate Pregnancy Outcomes in Female Participants Exposed to Subcutaneous (SC) Peginterferon Beta-1a and Intramuscular (IM) Interferon Beta-1a Reported in a German Participant Support ProgramWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-Remitting Biogen 470
Not applicableWithdrawnNCT00922831What this trial is testingProgression of Cognitive and Physical Symptoms in Multiple SclerosisWho this might be right forMultiple Sclerosis MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
Post-approval studies (Phase 4)Ended earlyNCT04877457What this trial is testingOcrelizumab for Preventing Clinical Multiple Sclerosis in Individuals With Radiologically Isolated Disease.Who this might be right forRadiologically Isolated SyndromeMultiple Sclerosis Yale University 3
Not applicableStudy completedNCT03480854What this trial is testingThe Multiple Sclerosis Continuous Quality Improvement (MSCQI) CollaborativeWho this might be right forMultiple Sclerosis Dartmouth-Hitchcock Medical Center 694
Not applicableStudy completedNCT03735056What this trial is testingThe PrEliMS Feasibility TrialWho this might be right forMultiple Sclerosis University of Nottingham 40
Not applicableLooking for participantsNCT04798651What this trial is testingPathogenicity of B and CD4 T Cell Subsets in Multiple SclerosisWho this might be right forMultiple SclerosisClinically Isolated Syndrome University Hospital, Bordeaux 150
Not applicableStudy completedNCT03555253What this trial is testingResilience-Based Program for Support Partners of Persons With Multiple SclerosisWho this might be right forMultiple Sclerosis Healios Inc. 62
Large-scale testing (Phase 3)Study completedNCT02587195What this trial is testingEvaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension PeriodWho this might be right forMultiple Sclerosis Centre Hospitalier Universitaire de Nice 5
Testing effectiveness (Phase 2)Ended earlyNCT00112723What this trial is testingFlavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaWho this might be right forAdult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more National Cancer Institute (NCI) 46
Not applicableLooking for participantsNCT05633875What this trial is testingMultimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple SclerosisWho this might be right forMultiple Sclerosis (MS) Assistance Publique - Hôpitaux de Paris 80
Early research (Phase 1)WithdrawnNCT00674141What this trial is testingNasal Administration of Dexamethasone for Multiple Sclerosis (MS) TreatmentWho this might be right forMS Patient With Relpasing Remitting Attacks Hadassah Medical Organization 10
Not applicableUnknownNCT06226831What this trial is testingOnset of Lower Urinary Tract Symptoms in Multiple Sclerosis PatientsWho this might be right forLower Urinary Tract SymptomsMultiple Sclerosis University Hospital Ostrava 1,500
Large-scale testing (Phase 3)UnknownNCT03691077What this trial is testingEffect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714Who this might be right forMultiple SclerosisRelapsePrimary Progressive Multiple Sclerosis Assistance Publique - Hôpitaux de Paris 51